WelTelOAKTREE: Text Messaging to Support Patients With HIV/AIDS in British Columbia (WelTelOAKTREE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02603536|
Recruitment Status : Completed
First Posted : November 11, 2015
Last Update Posted : February 2, 2017
|Condition or disease||Intervention/treatment||Phase|
|HIV Medication Adherence||Other: WelTel||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||85 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Repeated measures study. All participants acted as their own controls with data from year prior to intervention serving as control data and data from intervention year as intervention data.|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||WelTelOAKTREE: Text Messaging to Support Patients With HIV/AIDS in British Columbia|
|Actual Study Start Date :||April 2013|
|Actual Primary Completion Date :||May 2015|
|Actual Study Completion Date :||May 2016|
Experimental: Vulnerable or pilot participant
In addition to standard care, WelTel will send a weekly text message to participants in this arm for a one year period. Participants will be requested to respond to the outgoing message "How are you?" within 48 hours; they may respond that they are doing well or that they have a problem. A clinician will call to follow-up with all participants who respond indicating a problem or who do not respond within 48 hours.
An evidence-based, text messaging solution for improving patient adherence.
- Increased viral load/proportion of HIV viral load tests showing virologic suppression (< 40copies/ml) [ Time Frame: Two years ]Measured using lab results available in the patient charts in the intervention year compared to the year prior to enrollment.
- Number of hours spent by health care providers for this intervention [ Time Frame: Two years ]To inform future program development
- Improved engagement [ Time Frame: Two years ]Measured using attendance at outpatient visits in the intervention year compared to the year prior to enrollment.
- Increased CD4 counts [ Time Frame: Two years ]Measured using lab results available in the patient charts in the intervention year compared to the year prior to enrollment.
- Improved antiretroviral medication adherence [ Time Frame: Two years ]Measured using patient self-report data available in the patient charts in the intervention year compared to the year prior to enrollment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02603536
|Canada, British Columbia|
|Oak Tree Clinic|
|Vancouver, British Columbia, Canada, V6H 3N1|
|Principal Investigator:||Melanie Murray, MD,PhD,FRCPC||BC Women's Hospital & Health Centre|